[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-339235-en":59,"doc-seo-339235-105":98},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":72,"language_code":73,"site_id":74,"html_lang":73,"table_of_contents":75,"faqs":76,"seo_title":77,"seo_description":66,"update_tm":78,"read_time":79,"preview_page_count":19,"preview_urls":80},339235,3848291630094,"Emma Wilson","https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Clinical analysis of multiple primary gastrointestinal malignant tumors - A 10-year case review of a single-center - Retrospective Cohort Study","Background Multiple primary malignant tumors (MPMTs) have increasing incidence and may be influenced by better diagnostics, greater exposure to chemotherapy and radiotherapy, and prolonged cancer survival. Aim To analyze the incidence, clinical features, treatment factors, prevalence, tumor combinations, time intervals, staging, and prognosis of gastrointestinal MPMT patients in a single center. Methods A retrospective cohort study reviewed 8059 pathologically confirmed gastrointestinal malignancies (June 2011-June 2020); 85 patients had MPMTs.","| W | J | G | O | World Journal of\u003Cbr>Gastrointestinal Oncology |\n| --- | --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Gastrointest Oncol 2024 April 15; 16(4): 1204-1212  \nDOI: 10.4251/wjgo.v16.i4.1204 ISSN 1948-5204 (online)  \nORIGINAL ARTICLE  \nRetrospective Cohort Study  \nClinical analysis of multiple primary gastrointestinal malignant tumors: A 10-year case review of a single-center  \nCheng-Lou Zhu, Ling-Zhi Peng  \nSpecialty type: Oncology  \nProvenance and peer review:  \nUnsolicited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s scientific quality classification  \nGrade A (Excellent): 0  \nGrade B (Very good): 0  \nGrade C (Good): C  \nGrade D (Fair): 0  \nGrade E (Poor): 0  \nP-Reviewer: Ghannam WM, Egypt  \nReceived: January 13, 2024  \nPeer-review started: January 13, 2024  \nFirst decision: January 30, 2024  \nRevised: February 2, 2024  \nAccepted: March 6, 2024  \nArticle in press: March 6, 2024  \nPublished online: April 15, 2024  \nCheng-Lou Zhu, Ling-Zhi Peng, The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, Gansu Province, China  \nCheng-Lou Zhu, Ling-Zhi Peng, Department of Surgical Oncology, Gansu Provincial Hospital, Lanzhou 730000, Gansu Province, China  \nCorresponding author: Ling-Zhi Peng, MD, Chief Doctor, Department of Surgical Oncology, Gansu Provincial Hospital, No. 204 Donggang West Road, Chengguan District, Lanzhou 730000, Gansu Province, [China.](China. plz198996@163.com)[ plz198996@163.com](China. plz198996@163.com)  \nAbstract  \nBACKGROUND  \nMultiple primary malignant tumors (MPMTs) was first described by Billroth as early as 1889, with the first report published by Warren and Gates in 1932. Since then, numerous cases have been reported. A literature review of 1104269 patients with cancer revealed that the incidence of MPMTs ranged from 0.73 to 11.7% . In recent years, however, there has been a significant upward trend in the incidence of this phenomenon, which may be associated with many different factors, including the advancement of modern diagnostic procedures facilitating the examination and diagnosis of more MPMTs, increased exposure to chemotherapy and radiotherapy that exacerbate the risk of new malignant tumors in patients with cancer, and prolonged survival of patients with cancer allowing sufficient time for the development of new primary cancers.  \nAIM  \nTo analyze the incidence, clinical features, treatment factors, prevalence, and prognosis of patients with MPMTs in the gastrointestinal tract treated in a single center. Additionally, we analyzed the different tumor combinations, time interval between the occurrence of tumors, and staging.  \nMETHODS  \nThis retrospective cohort study analyzed 8059 patients with pathologically confirmed gastrointestinal malignant tumors treated at the Gansu Province Hospital in Lanzhou, Gansu, China between June 2011 and June 2020. Of these, 85 patients had MPMTs. The clinical features, treatment factors, prevalence, and prognosis of this latter cohort were analyzed.  \nRESULTS  \n WJGO  [https://www.wjgnet.com](https://www.wjgnet.com) 1204 April 15, 2024  Volume 16  Issue 4   \nZhu CL et al. Multiple primary gastrointestinal malignant tumors  \nThe incidence of MPMTs in patients with gastrointestinal malignant tumors was 1.05%(85/8059), including 83 double primary malignant tumors and two triple primary malignant tumors of which 57 (67.06%) were synchronous MPMTs (SMPMTs) and 28 (32.94%) were metachronous MPMTs (MMPMTs) . The most frequent associations were found between the rectum colon cancers within the SMPMT category and the gastric-colon cancers within the MMPMT category. For the MMPMTs, the median interval was 53 months. The overall 1-, 3-and 5-year survival rates from diagnosis of the first primary cancer were 91.36%, 65.41%, and 45.97%, respectively; those from diagnosis of the second primary cancer were 67.90%, 29.90%, and 17","cbCaipVrFoE97qN0","https://ap.wps.com/l/cbCaipVrFoE97qN0","pdf",735354,"English","en",105,"# Abstract\n## Background\n## Aim\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Definition of MPMTs","[{\"question\":\"What was the purpose of this study on multiple primary gastrointestinal malignant tumors?\",\"answer\":\"To analyze the incidence, clinical features, treatment factors, prevalence, and prognosis of gastrointestinal MPMT patients, including tumor combinations, time intervals between tumors, and staging.\"},{\"question\":\"How were patients selected for the retrospective cohort analysis?\",\"answer\":\"Pathologically confirmed gastrointestinal malignant tumors treated between June 2011 and June 2020 were reviewed; 85 of 8059 patients had MPMTs.\"},{\"question\":\"What did the results show about incidence and survival?\",\"answer\":\"The incidence of MPMTs was 1.05% (85/8059). Survival from diagnosis of the first primary cancer was 91.36%, 65.41%, and 45.97% at 1, 3, and 5 years, respectively, and prognosis was poor overall.\"}]","Clinical analysis of multiple primary gastrointestinal malignant tumors - A 10-year case review of a single-center - Retrospective Cohort Study | PDF",1790028909,25,[81,85,89,94],{"page_no":8,"url":82,"width":83,"height":84},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b47c853384dc4662338ffaef4109ec7.webp",983,1390,{"page_no":14,"url":86,"width":87,"height":88},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd28b43fc21090cc3ef557c070a89341.webp",982,1389,{"page_no":90,"url":91,"width":92,"height":93},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8aef63e423456317790b39d7aa6f8d6.webp",981,1387,{"page_no":19,"url":95,"width":96,"height":97},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc3cc92b791360eeb6502559a9bf1a3e.webp",980,1386,{"code":4,"msg":99,"data":100},"ok",{"site_id":74,"language":73,"slug":101,"title":65,"keywords":102,"description":66,"schema_data":103,"social_meta":156,"head_meta":158,"extra_data":160,"updated_unix":161},"clinical-analysis-of-multiple-primary-gastrointestinal-malignant-tumors-a-10-year-case-review-of-a-single-center-retrospective-cohort-study","",{"@graph":104,"@context":155},[105,118,138],{"@type":106,"itemListElement":107},"BreadcrumbList",[108,112,114,116],{"item":109,"name":110,"@type":111,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":113,"name":9,"@type":111,"position":14},"https://docshare.wps.com/document/",{"item":115,"name":40,"@type":111,"position":90},"https://docshare.wps.com/document/research-report/",{"item":117,"name":65,"@type":111,"position":19},"https://docshare.wps.com/document/clinical-analysis-of-multiple-primary-gastrointestinal-malignant-tumors-a-10-year-case-review-of-a-single-center-retrospective-cohort-study/339235/",{"url":117,"name":65,"@type":119,"image":120,"author":125,"headline":65,"publisher":127,"fileFormat":130,"inLanguage":73,"description":66,"dateModified":131,"datePublished":132,"encodingFormat":130,"isAccessibleForFree":133,"interactionStatistic":134},"DigitalDocument",{"url":121,"@type":122,"width":123,"height":124},"https://docshare.wps.com/thumbnails/clinical-analysis-of-multiple-primary-gastrointestinal-malignant-tumors-a-10-year-case-review-of-a-single-center-retrospective-cohort-study/339235.png","ImageObject",300,407,{"name":63,"@type":126},"Person",{"url":109,"name":128,"@type":129},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":135,"interactionType":136,"userInteractionCount":34},"InteractionCounter",{"@type":137},"ViewAction",{"@type":139,"mainEntity":140},"FAQPage",[141,147,151],{"name":142,"@type":143,"acceptedAnswer":144},"What was the purpose of this study on multiple primary gastrointestinal malignant tumors?","Question",{"text":145,"@type":146},"To analyze the incidence, clinical features, treatment factors, prevalence, and prognosis of gastrointestinal MPMT patients, including tumor combinations, time intervals between tumors, and staging.","Answer",{"name":148,"@type":143,"acceptedAnswer":149},"How were patients selected for the retrospective cohort analysis?",{"text":150,"@type":146},"Pathologically confirmed gastrointestinal malignant tumors treated between June 2011 and June 2020 were reviewed; 85 of 8059 patients had MPMTs.",{"name":152,"@type":143,"acceptedAnswer":153},"What did the results show about incidence and survival?",{"text":154,"@type":146},"The incidence of MPMTs was 1.05% (85/8059). Survival from diagnosis of the first primary cancer was 91.36%, 65.41%, and 45.97% at 1, 3, and 5 years, respectively, and prognosis was poor overall.","https://schema.org",{"og:url":117,"og:type":157,"og:title":65,"og:site_name":128,"og:description":66},"article",{"robots":159,"canonical":117},"index,follow",{"doc_id":61,"site_id":74},1790142795]